TRADING UPDATES: EnSilica hails "solid" half-year; Aptamer revenue up
7th Jan 2026 11:43
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 0.25p on 27-02-2026 at 19:35:07 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.26p |
| Sell | 0.24p |
| Last Trade: | Buy 1,800,000.00 at 0.252p |
| Day's Volume: | 47,525,243 |
| Last Close: | 0.25p |
| Open: | 0.24p |
| ISIN: | GB00BMD1Z199 |
| Day's Range | 0.24p - 0.25p |
| 52wk Range: | 0.1095p - 0.395p |
| Market Capitalisation: | £17.02m |
| VWAP: | 0.251724p |
| Shares in Issue: | 6.81b |
Sector: Medicine and Biotech
Solvonis Therap (SVNS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,800,000 | 0.252p | Ordinary |
16:14:40 - 27-Feb-26 |
| Buy* | 96,869 | 0.2568p | Ordinary |
15:55:15 - 27-Feb-26 |
| Buy* | 96,869 | 0.2568p | Ordinary |
15:54:15 - 27-Feb-26 |
| Buy* | 96,869 | 0.2568p | Ordinary |
15:52:57 - 27-Feb-26 |
| Buy* | 250,000 | 0.2568p | Ordinary |
15:49:08 - 27-Feb-26 |
| Buy* | 1,500,000 | 0.251p | Ordinary |
15:47:27 - 27-Feb-26 |
| Sell* | 233,350 | 0.24p | Ordinary |
15:37:39 - 27-Feb-26 |
| Buy* | 267,834 | 0.2568p | Ordinary |
15:35:53 - 27-Feb-26 |
| Buy* | 300,000 | 0.2518p | Ordinary |
15:33:27 - 27-Feb-26 |
| Sell* | 250,000 | 0.241p | Ordinary |
15:31:32 - 27-Feb-26 |
Solvonis Therap (SVNS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Jan 2026 7:00 am | RNS | Expansion of SVN-015 into depression |
| 7th Jan 2026 7:00 am | RNS | US Patent allowance for PTSD discovery programme |
| 22nd Dec 2025 7:00 am | RNS | Research and Development Update - Q4 2025 |
| 22nd Dec 2025 7:00 am | RNS | Research and Development Update – Q4 2025 |
| 3rd Dec 2025 7:00 am | RNS | SVN-015 accepted into US NIDA funded programme |
| 31st Oct 2025 3:59 pm | RNS | Total Voting Rights |
| 31st Oct 2025 7:00 am | RNS | Corporate Structure Update and Issue of Options |
| 27th Oct 2025 7:00 am | RNS | Appoints global biopharma leader Paul Carter |
| 16th Oct 2025 7:00 am | RNS | Raises £1.25 Million to Accelerate Programmes |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |